Title |
Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries
|
---|---|
Published in |
Malaria Journal, October 2011
|
DOI | 10.1186/1475-2875-10-326 |
Pubmed ID | |
Authors |
Kathryn A O'Connell, Hellen Gatakaa, Stephen Poyer, Julius Njogu, Illah Evance, Erik Munroe, Tsione Solomon, Catherine Goodman, Kara Hanson, Cyprien Zinsou, Louis Akulayi, Jacky Raharinjatovo, Ekundayo Arogundade, Peter Buyungo, Felton Mpasela, Chérifatou Bello Adjibabi, Jean Angbalu Agbango, Benjamin Fanomezana Ramarosandratana, Babajide Coker, Denis Rubahika, Busiku Hamainza, Steven Chapman, Tanya Shewchuk, Desmond Chavasse |
Abstract |
Artemisinin-based combination therapy (ACT) is the first-line malaria treatment throughout most of the malaria-endemic world. Data on ACT availability, price and market share are needed to provide a firm evidence base from which to assess the current situation concerning quality-assured ACT supply. This paper presents supply side data from ACTwatch outlet surveys in Benin, the Democratic Republic of Congo (DRC), Madagascar, Nigeria, Uganda and Zambia. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 50% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Netherlands | 1 | <1% |
Switzerland | 1 | <1% |
Unknown | 148 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 36 | 24% |
Researcher | 28 | 19% |
Student > Ph. D. Student | 15 | 10% |
Student > Doctoral Student | 9 | 6% |
Lecturer | 8 | 5% |
Other | 23 | 15% |
Unknown | 32 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 30 | 20% |
Social Sciences | 22 | 15% |
Agricultural and Biological Sciences | 15 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 7% |
Nursing and Health Professions | 9 | 6% |
Other | 24 | 16% |
Unknown | 40 | 26% |